Cargando…
A(2A) blockade enhances anti-metastatic immune responses
The specific targeting of tumor-elicited immunosuppression is a promising strategy for the treatment of cancer. We have recently demonstrated that targeting the immunosuppressive pathway mediated by CD73-derived adenosine through the blockade of A(2A)/A(2B) adenosine receptors significantly reduced...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926871/ https://www.ncbi.nlm.nih.gov/pubmed/24575377 http://dx.doi.org/10.4161/onci.26705 |